OVERVIEW

8th Annual Transplant Quality Institute (TQI) is organized by American Foundation for Donation and Transplantation (AFDT) and will be held from Oct 19 - 21, 2022 at Hilton Atlanta, Atlanta, Georgia, United States of America.

Objectives:
Following the one-day Foundational Concepts course participants will be able to:
• Describe the essential aspects of transplant rules and regulations, QAPI structure, quality metrics, adverse event management, and QAPI reports
• Discuss specific policies and regulations related to Transplant Quality
• Identify emerging challenges within transplant quality programs

Following the three-day Transplant Quality Institute Conference participants will be able to:
• Discuss current and new initiatives of OPTN/UNOS
• Describe current and new SRTR performance metrics
• Explain the new CMS OPO outcome metrics
• Describe the NASEM report regarding kidney transplants and possible implications for transplant quality
• Describe the impact of broader sharing on transplant programs and OPOs
• Describe efforts to improve quality surveillance and reporting by leveraging EMR technology
• Describe utilization strategies of organs from Covid-19 donors
• Describe how the transplant program could participate in their hospital donation council
• Discuss the implications of broader use of DCD donors
• Describe how the Improving Renal Outcomes Collaborative is driving quality in pediatric kidney transplantation
• Discuss how increasing numbers of value-based care models are impacting transplant programs
• Describe how health care workers can develop resilience

Additional details will be posted as soon as information is available

KEY DATES

Event Start Date
19 Oct, 2022
Event Start Date
Event End Date
21 Oct, 2022
Event End Date

TARGET AUDIENCE

PhysicianNephrologistsTransplant Surgeons

SPECIALITIES

NephrologyTransplant Surgery

SUGGESTED HOTELS

CONFERENCE VENUE

LocationHilton Atlanta
255 Courtland St NE

RELATED CONFERENCES & LIVE WEBINARS

Oct 26 - 27, 2026 | Paris, ...

Hepatology
More actions
FR€400